Abstract
Transarterial chemoembolization consists in the administration of chemotherapy while a contemporaneous embolization of the tumor’s vascular feeders is performed. This chapter describes the rationale and the historical steps that brought from the first arterial access and catheterization to the creation and successive development of this technique, which is mainly applied to liver’s malignancies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kudo M. The 2008 Okuda lecture: management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. Vol. 25, Journal of gastroenterology and hepatology (Australia). J Gastroenterol Hepatol. 2010;25:439–52.
Werner Forssmann–Biographical. NobelPrize.org. Nobel prize outreach AB 2022. Sun. 22 May 2022. https://www.nobelprize.org/prizes/medicine/1956/forssmann/biographical/
Farinas LP. A new technique for the arteriographic examination of the abdominal aorta and its branches. Am J Roentgenol. 1941;
Peirce EC. Percutaneous femoral artery catheterization in man with special reference to aortography. Surg Gynaecol Obstet. 1951;133:544.
Seldinger SI. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol. 1953 May 1;39(5):368–76.
Nusbaum M, Baum S. Radiographic demonstration of unknown sites of gastrointestinal bleeding. Surg Forum. 1963;14:374–5.
Luessenhop AJ, Kachmann R Jr, Shevlin W, Ferrero AA. Clinical evaluation of artificial embolization in the management of large cerebral arteriovenous malformations. J Neurosurg. 1965;23(4):400–17.
Nusbaum M, Baum S, Blakemore WS, Finklstein A. Demonstration of intra-abdominal bleeding by selective arteriography. Visualization of celiac and superior mesenteric arteries. JAMA. 1965 Feb 1;191:389–90. https://doi.org/10.1001/jama.1965.03080050035009.
Nusbaum M, Baum S, Blakemore WS. Clinical experience with the diagnosis and management of gastrointestinal hemorrhage by selective mesenteric catheterization. Ann Surg. 1969;170:506–14.
Baum S, Nusbaum M. The control of gastrointestinal hemorrhage by selective mesenteric arterial infusion of vasopressin 1 diagnostic radiology. Radiology. 1971;98:497.
Rösch J, Dotter CT, Brown MJ. Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology. 1972 Feb;102(2):303–6. https://doi.org/10.1148/102.2.303.
Doppman JL, di Chiro G, Ommaya AK. Percutaneous embolization of spinal cord arteriovenous malformations.
Almgard LE, Fernstrom I, Ljungqvist A. Treatment of renal adenocarcinoma by embolic occlusion of the renal circulation. Br J Urol. 1973;45:474.
Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C. Transcatheter occlusion of abdominal tumors 1.
Wheeler PG, Melia W, Dubbins P, Jones B, Nunnerley H, Johnson P, et al. Non-operative arterial embolisation in primary liver tumours, vol. 28. Br Med J; 1979. p. 242.
Yamada R, Nakatsuka H, Nakamura K, et al. Transcatheter arterial embolization therapy in unresectable hepatomas-experience in 15 cases. Acta Hepatologica Japonica (Tokyo). 1979;20:595.
Reuter SR. The current status of angiography in the evaluation of cancer patients. Cancer. 1976;37:532–41.
Murray-Lyon IM. Treatment of hepatic tumours by ligation of the hepatic artery and infusion of cytotoxic drugs. J R Coll Surg Edinb. 1972;17:156–61.
Lucas RJ, Tumacder O, Wilson GS. Hepatic artery occlusion following hepatic artery catheterization. Ann Surg. 1971;173:238–43.
Cleveland JC. Inadvertent interruption of hepatic arterial flow.
Roscoe Graham BR, Cannell D. Accidental ligation of the hepatic artery. report of one case, with a review of the cases in the literature.
Doyon D, Mouzon A, Jourde AM, Regensberg C, Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours. Ann Radiol. 1974;17:593–603.
Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms 1.
Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Interventional radiology hepatic artery embolization in 120.
Nakakuma K, Tashiro S, Hiraoka T, Uemura K, Konno T, Miyauchi Y, Yokoyama I. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer. 1983 Dec 15;52(12):2193–200. https://doi.org/10.1002/1097-0142(19831215)52:12<2193::aid-cncr2820521203>3.0.co;2-r.
Friedman MA, Volberding PA, Cassidy MJ. Therapy for hepatocellular cancer with intrahepatic arterial Adriamycin and 5-fluorouracil combined with whole-liver irradiadiation: a northern California oncology group study. Cancer Treat Rep. 1979;63:1885–8.
Misra NC, Jaiswal MSD, Singh RV, Das B. Intrahepatic arterial infusion of combination of mitomycin C and 5 fluorouracil in treatment of primary and metastatic liver carcinoma. Cancer. 1977;39:1425–9.
Hirose H, Aoyama M, Oshima K, et al. Chemotherapy of hepatocellular carcinoma–with special reference to one-shot intra-arterial infusion of a high dose of adriamycin. Gan To Kagaku Ryoho. 1982;9:2216–21.
Dakhil S, Ensminger W, Cho K, John Niederhuber Md, Doan KR, Wheeler R, et al. Improved regional selectivity of hepatic arterial bcnu with degradable microspheres.
Wollner IS, Walker-Andrews SC, Smith JE, Ensminger WD. Phase II study of hepatic arterial degradable starch microspheres and Mitomycin. Cancer Drug Deliv. 1986;3:279.
Carr BI, Zajko A, Bron K, Orons P, Sammon J, Baron R. Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis. Semin Oncol. 1997;24(2 Suppl 6):S6-97–9.
Li X, Feng G-S, Zheng C-S, Zhuo C-K, Liu X. Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study. World J Gastroenterol. 2003 Nov 9;9:2445.
Lucatelli P, Burrel M, Guiu B, de Rubeis G, Van Delden O. Thomas Helemberg. CIRSE standards of practice on hepatic transarterial chemoembolisation. Cardiovasc Intervent Radiol. 2021;44:1851.
Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995 May 11;332(19):1256–61. https://doi.org/10.1056/NEJM199505113321903.
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003 Feb;37(2):429–42. https://doi.org/10.1053/jhep.2003.50047.
Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006 Feb;17(2):335–42.
Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol. 2006 Aug;17(8):1335–43.
Hong K, Khwaja A, Liapi E, Torbenson MS, Georgiades CS, Geschwind JFH. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006 Apr 15;12(8):2563–7.
Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007 Mar;46(3):474–81.
Poon RTP, Tso WK, Pang RWC, Ng KKC, Woo R, Tai KS, et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007;5(9):1100–8.
Malagari K, Chatzimichael K, Alexopoulou E, Kelekis A, Hall B, Dourakis S, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol. 2008 Mar;31(2):269–80.
de Baere T, Deschamps F, Teriitheau C, Rao P, Conengrapht K, Schlumberger M, et al. Transarterial chemoembolization of liver metastases from well differentiated Gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol. 2008 Jun;19(6):855–61.
Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION v study. Cardiovasc Intervent Radiol. 2010;33(1):41–52.
Irie T. Improved accumulation of lipiodol under balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma: measurement of blood pressure at the embolized artery before and after balloon inflation.
Lucatelli P, Ginnani Corradini L, de Rubeis G, Rocco B, Basilico F, Cannavale A, et al. Balloon-occluded Transcatheter arterial chemoembolization (b-TACE) for hepatocellular carcinoma performed with polyethylene-glycol Epirubicin-loaded drug-eluting Embolics: safety and preliminary results. Cardiovasc Intervent Radiol. 2019 Jun 15;42(6):853–62.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rocco, B., Camelo, V., Feliciangeli, V., Catalano, C., Lucatelli, P. (2023). Rationale, Definition, and History of Transarterial Chemoembolization. In: Lucatelli, P. (eds) Transarterial Chemoembolization (TACE) . Springer, Cham. https://doi.org/10.1007/978-3-031-36261-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-36261-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36260-6
Online ISBN: 978-3-031-36261-3
eBook Packages: MedicineMedicine (R0)